| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 300049 from our risk checks.
Inner Mongolia Furui Medical Science Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥51.95 |
| 52 Week High | CN¥57.50 |
| 52 Week Low | CN¥28.73 |
| Beta | -0.33 |
| 11 Month Change | 45.36% |
| 3 Month Change | 8.00% |
| 1 Year Change | 43.47% |
| 33 Year Change | 342.50% |
| 5 Year Change | 554.28% |
| Change since IPO | 412.08% |
Recent News & Updates
Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%
Oct 17
Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today
Sep 02Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price
Jul 21Recent updates
Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%
Oct 17Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today
Sep 02Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price
Jul 21With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case
May 24We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease
Apr 29Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)
Feb 28Shareholder Returns
| 300049 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 17.2% | 1.6% | 2.7% |
| 1Y | 43.5% | 0.7% | 4.6% |
Return vs Industry: 300049 exceeded the CN Pharmaceuticals industry which returned -3.6% over the past year.
Return vs Market: 300049 exceeded the CN Market which returned 0.1% over the past year.
Price Volatility
| 300049 volatility | |
|---|---|
| 300049 Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in CN Market | 11.4% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300049 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300049's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 703 | Guanyi Wang | www.fu-rui.com |
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales.
Inner Mongolia Furui Medical Science Co., Ltd. Fundamentals Summary
| 300049 fundamental statistics | |
|---|---|
| Market cap | CN¥13.82b |
| Earnings (TTM) | CN¥133.11m |
| Revenue (TTM) | CN¥1.27b |
103.8x
P/E Ratio10.9x
P/S RatioIs 300049 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300049 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.27b |
| Cost of Revenue | CN¥329.35m |
| Gross Profit | CN¥942.53m |
| Other Expenses | CN¥809.42m |
| Earnings | CN¥133.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 24, 2024
| Earnings per share (EPS) | 0.50 |
| Gross Margin | 74.11% |
| Net Profit Margin | 10.47% |
| Debt/Equity Ratio | 0% |
How did 300049 perform over the long term?
See historical performance and comparison